Health Care Technology

This morning’s top day trader and active trader alerts are mostly not tied to earnings.  The cast of characters today includes AEterna Zentaris, Inc. (NASDAQ: AEZS), American Superconductor Corporation (NASDAQ: AMSC), Fresenius Kabi Pharmaceuticals (NASDAQ: APCVZ), Double-Take Software, Inc. (...

Acacia Research Corp (NASDAQ: ACTG) crossed its earlier 52-week high of $15 and created a new 52-week high of $15.15, up 1.81% at 12:51 pm. ACTG’s Document Generation Corporation subsidiary has entered into a settlement agreement with Cerner Corporation (NASDAQ: CERN) covering patents relating to...

Wall Street got a pounding for the third consecutive day. While the Dow Jones Industrial Average dipped 141.63, or 1.30%, to 10,726.49, Nasdaq moved down 42.58, or 1.77%. Some of the few narrow based indexes that are driving the market are the Pharmacy Benefit Manager Stocks, which have gained 2%,...

Auriga analyst Gene Mannheimer reiterated his Buy rating for shares of Eclipsys Corporation (NASDAQ: ECLP), with a price target of $24. Mannheimer noted that Eclipsys Corporation recently reported mixed financial results, beating Auriga's earnings estimates, while missing the revenue forecast. The...

Analyst Gene Mannheimer at Auriga has raised the price target for Cerner Corporation (NASDAQ: CERN) from $85 to $87. The company reported its first-quarter results on Wednesday. Cerner reported first-quarter EPS of $0.63, compared with Auriga’s estimate of $0.60 and consensus of $0.61. Revenue...

Brean Murray, Carret and Co. analyst Bret Jones said that because of the pending acquisition of Phase Forward Incorporated (NASDAQ: PFWD) by Oracle Corporation (NASDAQ: ORCL) , his firm was suspending coverage of the company until the deal closes. The acquisition is expected to be finalized before...

Analyst Glenn Garmont of ThinkEquity Partners maintains his "buy" rating on Omnicell, Inc (NASDAQ: OMCL). OMCL is set to announce its Q1 results on April 26 after the market closes. According to ThinkEquity Partners, the company will report “revenue/non-GAAP EPS of $53M/$0.09, both roughly in line...

Battle Road Research has downgraded Phase Forward Incorporated (NASDAQ: PFWD) from Buy to Sell rating following Friday’s announcement by Oracle Corporation (NASDAQ: ORCL) that it intends to acquire the company. Oracle will acquire Phase Forward for $685 million, or $17 per share in an all cash deal...

Merger and acquisition activity continues to heat up with 5 new mergers announced last week and two deals closing. The pace of merger activity over the last few weeks combined with an uptick in IPOs (5 new offerings were filed last week) and heavy insider selling have me very worried about this...

The Wall Street Journal reports that Oracle Corporation (NASDAQ: ORCL) announced that it will acquire Phase Forward Incorporated (NASDAQ: PFWD) for $685 million in cash. The acquisition will enable Oracle to sell specialized software to pharmaceuticals and health-care companies. Shares of Oracle...

Phase Forward Incorporated (NASDAQ: PFWD) shares gained 28.40% to $16.80. The volume of PFWD shares traded was 10278% higher than normal. The company has agreed to be acquired by Oracle (NASDAQ: ORCL). Medidata Solutions, Inc (NASDAQ: MDSO) shares climbed 5.76% to $ 16.17. The volume of MDSO shares...

Software Company Oracle Corp. (NASADQ:ORCL) is planning to acquire Phase Forward (NASDAQ: PFWD). Phase Forward (PFWD) is a drug data management software company. The deal is expected to be worth $685 million. Oracle (ORCL) hopes to boost its health sciences business with this deal. According to...

Despite reports showing a rise in home construction and permits for future building, stock futures point to a lower opening. Investor sentiments are being weighed down by lower-than-expected earnings from Google (NASDAQ: GOOG) and Advanced Micro Devices (NYSE: AMD). S&P futures fell 0.47%....

Despite reports showing a rise in home construction and permits for future building, stock futures point to a lower opening. Investor sentiments are being weighed down by lower-than-expected earnings from Google (NASDAQ: GOOG) and Advanced Micro Devices (NYSE: AMD). S&P futures fell 0.47%....

Phase Forward Incorporated (NASDAQ: PFWD) jumped 28.90% to $16.86 in the pre-market session. Oracle (NASDAQ: ORCL) has agreed to pay $17 a share in cash to buy PFWD, reflecting a 30% premium. ImmunoGen, Inc (NASDAQ: IMGN) has risen 8.00% to $9.72 in pre-market trading. IMGN is involved in the...